Safety

Cleocin T (clindamycin phosphate) lotion, solution, and gel, 1 Percent

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

January 2016

Summary View

ADVERSE REACTIONS

  • addition of adverse events of eye pain and contact dermatitis

 

April 2014

Summary View

PRECAUTIONS

Pregnancy: Teratogenic effects—Pregnancy Category B
  • In clinical trials with pregnant women, the systemic administration of clindamycin during the second and third trimesters, has not been associated with an increased frequency of congenital abnormalities. There are no adequate studies in pregnant women during the first trimester of pregnancy. Clindamycin should be used during the first trimester of pregnancy only if clearly needed.

 

Page Last Updated: 02/12/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.